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ABSTRACT
Background: Lymphangiosarcoma (LSA) is a rare, highly malignant and infiltrative neoplasm of the lymphatic endothe-
lium of dogs and cats. It is mostly reported in medium to large breed dogs, over 5-year-old, with no sexual predisposi-
tion. Affected animals present fluctuating and diffuse swelling, covering both dermis and subcutaneous tissue, spreading 
through lymphatic and haematic vessels. Histologically, LSA is characterized by connected channels devoid of conspicuous 
haematic elements. Treatment depends on location of the neoplasm, staging, and possibility of curative surgical excision. 
Chemotherapy and radiotherapy can increase survival time. In this report, we describe a rare case of vulvar LSA in a dog. 
This is the first Brazilian report of LSA in dogs so far.
Case: A 3-year-old, female, mixed breed dog was presented for evaluation of vesicle-bullous lesions in the vulvar and 
perivulvar region with progressive growth along 6 month. Histopathology revealed neoplastic proliferation in the superficial 
dermis, advancing through the profound dermis. The histological lesion pattern was consistent with angiosarcoma, which 
united along with macroscopic pattern of the tumor, and the presence of multiple anastomosed vascular structures without 
erythrocytes within it at microscopy, was compatible with LSA. No evidence of metastasis or lymphadenopathy was found 
on survey radiography and ultrasound. We performed a surgical excision, and remaining wound was reconstructed with 
an advancement skin flap. Despite wide surgical resection, neoplastic cells could be found in surgical borders, as well as 
a metastatic inguinal lymph node. Postoperative chemotherapy based on doxorubicin as a single agent was administrated. 
Disease free interval (DFI) was one month after surgery, when small bullous lesions were observed near the surgical site, 
and histopathological exam confirmed LSA. Three months after the surgical procedure, the patient presented with worsen-
ing of the lesions, anorexia, and apathy. The owner opted for euthanasia. Total survival time was five months.
Discussion: The LSA occurs often in dogs above five years old, unlike this case, in which the patient was 3 years old. 
Several anatomic locations were cited in other reports. In this case, the lesion was in both the vulvar and perivulvar regions, 
which is an uncommon location of LSA, described as secondarily affected region in one report only. Despite absence of 
metastasis in this case, lungs, kidneys, bone marrow, and spleen can be affected. Histopathologic exam is the golden standard 
for a definitive diagnose of LSA. Diagnosing LSA may be challenging due to its resemblance to hemangiosarcoma, and 
confirmation is only possible if histopathology detects an absence of red blood cells in the lymphatic channels. Prognosis 
is poor due to LSA aggressive and infiltrative features. Doxorubicin demonstrated good clinical response in other dogs. 
Chemotherapy protocols, whether alone or in combination with cyclophosphamide, have been proving to be promising 
in dogs with soft tissue sarcomas, such as LSA. Surgical approach is the most appropriate and it may be associated with 
radiotherapy or chemotherapy, especially if complete resection of the tumor is not possible. In this report, even though it 
was a young animal, the location and extension of the lesion did not contribute to the good prognosis, even after adding 
adjuvant chemotherapy to the treatment.
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INTRODUCTION
The lymphangiosarcoma (LSA) is a rare, 
highly malignant and infiltrative neoplasm that origi-
nates from the cells of the lymphatic endothelium of 
dogs and cats [25]. It is mostly reported in medium 
to large breed dogs, over 5 years old, with no sexual 
predisposition [17,23].
Macroscopically, they are usually edematous 
and soft, and quickly infiltrate the underlying tissue, 
spreading through lymphatic and haematic vessels 
[4,17]. Affected animals present a fluctuating, diffuse, 
and sometimes painful swelling, covering both dermis 
and subcutaneous tissue [4].
In humans, its occurrence is usually related 
to the presence of chronic lymphedema [4].  It is sug-
gested that the persistent presence of interstitial fluid 
rich in proteins or the chronic physical pressure in 
the lymphatic endothelium may be a stimulator for 
neoplastic transformation [6].
The golden standard for diagnose is histo-
pathology. Histologically, LSA is characterized by 
connected channels devoid of conspicuous haematic 
elements, and coated by large and atypical endothelial 
cells through edematous collagen trabeculae [4]. The 
treatment depends on location of the neoplasm, clinical 
staging, and possibility of surgery with complete surgi-
cal excision [25]. Chemotherapy can increase survival 
time, but few articles describe different protocols and 
follow-ups in dogs [3,8,11,12,18].
This report describes a case of a young female 
dog affected by LSA, unusually located in both vulvar 
and perivulvar region, submitted to surgical resection 
and adjuvant chemotherapy with doxorubicin. This is 
the first Brazilian case report of LSA in dogs so far.
CASE
A 3-year-old, unneutered, female mixed-breed 
dog, weighting 12 kg, was presented for evaluation of 
vesicle-bullous lesions with progressive growth along 
6 months. During physical exam, a painful, fluctuat-
ing bullous lesion characterized by an erythematous 
base, its sero-hemorrhagic content, and poorly defined 
dermographic margins was detected in the perivulvar 
region, extending to the vulvar, inguinal and medial 
thigh regions (Figure 1).
Initially, a fine needle aspiration for cytological 
examination revealed a hypercelular sample, contami-
nated with blood and characterized by the predomi-
nance of lymphocytes, vacuolized macrophages, rare 
neutrophils, and no bacteria, characterizing inflam-
mation. Fusiform cells with abundant cytoplasm, at 
times binucleated with sparse chromatin, evident nu-
cleoli and presence of mitotic figures were visualized. 
Complete blood count and biochemical analysis were 
within normal limits for the specie. Thoracic radiog-
raphy and abdominal ultrasound were performed and 
no evidence of signs compatible with metastasis or 
lymphadenopathy was found.
Subsequently, patient was submitted to inci-
sional biopsy for histopathological exam. The micro-
scopic aspect showed neoplastic proliferation in the 
superficial dermis, advancing through the profound 
dermis and a portion of panniculus adipose with 
poorly defined borders. The neoplastic cells were 
small, poorly differentiated, globular, and proliferated 
forming multiple anastomosed vascular structures, 
which were optically empty. There was stromal edema 
accompanied by mild infiltration of lymphocytes and 
plasma cells. Anisocariose, anisocytosis, and nuclear 
atypia were noted.
The mitotic index was <1 m.f./40x. The his-
tological lesion pattern was consistent with angiosar-
coma, which united along with macroscopic pattern 
of the tumor and the lack of erythrocytes within the 
vascular space at microscopy, was compatible with 
LSA (Figure 2). 
A wide surgical excision was performed after 
histopathological results, and an advancement skin flap 
from the lateral face of the left hind limb was necessary 
to cover the surgical defect (Figure 3).
Despite wide surgical resection and adequate 
healing, a histopathological exam of the excised tissue 
revealed compromised margins and a metastatic ingui-
nal lymph node. We decided to associate chemotherapy 
with doxorubicin (30 mg/m²) every three weeks. One 
month after surgical resection, small bullous lesions 
were observed near the surgical site, and histopa-
thology confirmed the recurrence of the neoplasia. 
However, due to persistent hematological changes, 
chemotherapy was discontinued after the third cycle. 
Two months after the last session with doxorubicin, 
the patient returned with worsening of the clinical 
condition, presenting ulcerated lesions with serosan-
guineous fluid in the perivulvar and inguinal regions, 
anorexia, and apathy. The owner opted for euthanasia. 
Total survival time was five months.
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It has been reported 33 cases of LSA until this 
moment [1,3-6,8-16,18-22,24]. There is no sexual 
predisposition for this kind of tumor. However, a retro-
spective study [23] revealed that most part of reported 
cases were males (9 males - 56.25%). Nonetheless, in 
recent literature, females were more affected, in ac-
cordance with the present report (18 females - 55%) 
[3,4,9,12,14,16,19,21,24].
The predominant age group for this type of 
neoplasm is above five years old [3,8,10,12-16,19-21], 
unlike this case, in which the patient was three years 
old. There is no racial predisposition for LSA, but it 
has been noticed that it occurs more in medium to large 
breeds [1,3-6,8-10,12,13,16,20,21,24]. 
 Several anatomic locations were cited, 
such as head, cervical region, and thoracic inlet 
[3,5,6,8,14], inguinal region, prepuce and extremities 
[3,10,11,16,18,22], axillar region [1,3,4,9,16], thoracic 
subcutaneous tissue [3,13,19], thoracic cavity and 
mediastinum [15,20,21], and caudal abdomen [12,24]. 
In this report, the lesion was in both the vulvar and 
perivulvar regions, similar to one report only, where 
vulvar area was secondarily affected [16].  The inguinal 
lymph node was affected and there were no signs of 
metastasis in other organs. However, lungs, kidneys, 
bone marrow, and spleen can be affected [4]. 
 Image exams, such as radiography, abdominal 
ultrasound or computerized tomography (CT) and mag-
netic resonance imaging (MRI), can be done to search 
for metastatic lesions. Both CT and MRI can also assist 
surgical planning, as they determine wound limits [25].
Routine laboratory tests are performed, such as 
complete blood cells count, serum biochemistry [25], 
and urinalysis [3].  Results of blood samples are usually 
within normal reference values [1,3,4,12,22], as in this 
case. Nonrtheless, authors report lymphopenia [8,20,21], 
neutrophilia [10,11], nonregenerative anemia [3], regen-
erative anemia [3,5], neutropenia [3], azotemia [3,10], 
hypokalemia [5], hyperkalemia [10], hypoproteinemia 
[5,10], hypoalbuminemia [5], and hyponatremia and 
hypercloremia [10] in animals with LSA.
Although fine needle aspiration has limited 
utility in the diagnose of LSA [25], this procedure not 
only helped excluding differential diagnoses such as 
abscesses and cysts, but also showed presence of cellular 
atypia and mitosis characteristic of neoplasm process.
Histopathologic exam is the golden standard 
for a definitive diagnose of LSA [12]. Excisional bi-
Figure 1. A and B- Images from physical exam showing bullous, erythema-
tous and fluctuating aspect of the lesion.
Figure 2. Photomicrograph of the lymphangiossarcoma describe in this 
report. A- Notice the disorganized proliferating mesenquimal cells forming 
multiple empty anastomosed vascular spaces (arrow) [H&E, 50x]. B- Higher 
magnification of the left picture [H&E, 400x].
Figure 3. A and B- Pre-operative images evidencing the neoplasm as a 
fluctuating lesion with poorly defined margins; C- Trans-operative of wide 
tumor excision; D- Post-operative aspect of the site, after rotational skin flap.
DISCUSSION
LSA reports in dogs were published in 
England [12],  Australia [9],  United States 
[3,5,6,10,11,13,15,16,18,21], Argentina [4], Canada 
[1,20,22], South Africa [24], Japan [8,14,19]. This is 
the first report of this neoplasm in Brazil so far. 
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opsy is not recommended because it is rarely curative, 
and the subsequent surgery to excise complete histo-
logical margins is generally more aggressive than the 
surgery followed by punch or incisional biopsy [25]. 
Diagnosing LSA may be challenging due to its 
resemblance to hemangiosarcoma, and confirmation 
relies on lack of erythrocytes within the vascular spaces 
[12], as well as in stromal edema with lymphoplasma-
cytic infiltration [7]. Immunohistochemistry may also 
help in differentiation of angiosarcoma of vascular ori-
gin from angiosarcoma of lymphatic origin. In humans, 
it is based on expression of CD44 and podocalyxin by 
the former versus lymphatic vessel endothelial recep-
tor-1 (LYVE-1), podoplanin, and vascular endothelial 
growth factor receptor-3 (VEGFR-3) by the latter [7]. 
One study of 12 cases of lymphangiosarcoma in dogs 
confirmed the application of a lymphatic endothelial 
cell-specific marker, PROX-1, to differentiate between 
lymphangiosarcoma  and hemangiossarcoma [3].
In this report, diagnose was achieved by means 
of histopathological exam, that showed similar findings 
described in literature about this neoplasm. Mitosis 
are not common in this tumor [4,9], but this patient 
presented intense neoplastic proliferation with no 
apparent demarcations, and with few differenced and 
globous cells, though small and with low mitotic rate. 
Empty vascular channels, typical of this neoplasm, 
were visualized on histopathological exam. Due to its 
aggressive and infiltrative characteristic, prognosis of 
animals presented with LSA is poor [25]. In this case, 
wide surgical excision was not enough to guarantee free 
margins. Additionally, the involvement of the inguinal 
lymph node associated with the presence of mitosis 
confirmed the invasive character of this neoplasm. 
Adjuvant chemotherapy was added to treat-
ment in order to increase the patient’s survival time. 
There are eight cases described in literature which 
mention the use of chemotherapy in addition to surgical 
excision of LSA. The most used agent was doxorubicin 
[3,8,11,12], followed by carboplatin [3], lomustin [3], 
mitoxantrone [20], metronomic with clorambucil [3, 
12] and ciclophosphamide [3]. Radiotherapy was also 
used in one report [13], and it resulted in a four months 
of disease free interval (DFI), as shown in Table 1.
The chemotherapy agent chosen was doxorubi-
cin, as it had demonstrated to have good clinical response 
Reference 
/year Surgery Agents/therapy cited Number of sessions
Disease free 
interval
Follow-up time 
reported
17 (1996) Yes Derivate of doxorubicin Six Five months Six months
7 (2004) Yes Doxorubicin Four Nine months -
10 (2007) Yes Radiotherapy associated 
with doxorubicin Four Four months Fifteen months
21 (2012) Yes Mitoxantrone Six Ten months Ten months
11 (2013) Yes
(A) Doxorubicin 
(B) Metronomic with 
Clorambucil 
(C) Metronomic with 
Clorambucil + Palladia 
(A)  Five
(B) Two months, 
daily
(C) Two weeks 
(interleaved days)
(A) Six months
(B) Zero
(C) Regression 
of tumor
Fourteen 
months
3 (2014)
1) No
2) Yes
3) Yes
Case 1: Doxorubicin 
+ ciclophosphamid 
metronomic
Case 2: Carboplatine
Case 3: (A) Radiation 
+ doxorubicin and 
lipossomal doxorubicin
(B) Lomustine (rescue 
protocol)
1) Five
2) Four
3) (A) Four
3) (B) One
1) 182 days
2) 75 days
3) (A) 240 days
3) (B) Zero
-
Table1. Chemotherapy protocols for LSA described in literature.
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in other dogs [3,8,11,12,18]. Chemotherapy protocols 
including doxorubicin, whether alone or in combina-
tion with cyclophosphamide, have been proving to be 
promising in dogs with soft tissue sarcomas, such as 
LSA [25], as it is demonstrated in a clinical study [3].
This patient had DFI of one month, during the 
chemotherapy treatment, and survival time was five 
months. The DFI was considered short when compared 
to other reports [3,8,11,12,18] probably because of 
histopathologic features, lymph node involvement, and 
absence of free surgical margins. Fewer chemotherapy 
sessions were performed compared to other reports 
[3,8,11,12,18], suggesting that longer protocols could 
improve remission time, between six and nine months. 
Other authors proposed the use of a similar protocol, 
after surgical resection of the mass, using doxorubicin 
as a single chemotherapic agent for four sessions [8]. 
Although free surgical margins were not achieved, the 
remission time was 9 months, but no metastatic site 
was found [8], unlike the results in this report.
In other protocols [3, 11], association of two or 
more chemotherapy agents were used to allow a superior 
time of remission of the disease/survival time in patients, 
especially if treatment is associated with radiotherapy.
Radiotherapy can be used as an adjuvant to 
surgery, whether with excision of complete margins or 
not, and it can be done in pre-op, post-op or as a single 
therapy, to treat and control pain [25]. However, this 
mode of therapy is not widely available yet. 
Surgical approach is most appropriate and it 
may be associated with radiotherapy or chemotherapy, 
especially if full resection of the tumor is not possible 
[25]. In this report, although it was a young animal, 
the location and extension of the lesion, associated 
with malignancy of the neoplasm, did not contribute 
to a good prognosis, even after adding adjuvant che-
motherapy to the treatment.
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